Levetiracetam (LEV) is an effective antiseizure medicine, but 10%-20% of people treated with LEV report psychiatric side-effects, and up to 1% may have psychotic episodes. Pharmacogenomic predictors of these adverse drug reactions (ADRs) have yet to be identified. We sought to determine the contribution of both common and rare genetic variation...
-
2022 (v1)PublicationUploaded on: February 14, 2024
-
2022 (v1)Publication
Epilepsy is a brain network disorder with associated genetic risk factors. Here, the authors show that spatial patterns of transcriptomic vulnerability co-vary with structural brain network alterations in focal and generalized epilepsy.Epilepsy is associated with genetic risk factors and cortico-subcortical network alterations, but associations...
Uploaded on: February 14, 2024